Risk of relapse of multiple myeloma following kidney transplantation

BACKGROUND: Autologous stem cell transplantation (ASCT) and novel therapies have improved the prognosis for patients with multiple myeloma (MM). For those who undergo ASCT while on dialysis, a similar survival compared with the overall MM population has been reported. Therefore, for patients achievi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sapna, Ibrahim, Maria, Delaney, Michael, Schey, Steve, Bygrave, Ceri, Streetly, Matthew, Benjamin, Reuben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Onconephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452174/
https://www.ncbi.nlm.nih.gov/pubmed/30976399
http://dx.doi.org/10.1093/ckj/sfy137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452174/
https://www.ncbi.nlm.nih.gov/pubmed/30976399
http://dx.doi.org/10.1093/ckj/sfy137

Ejemplares similares